{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T10:29:53Z","timestamp":1714300193917},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1996,7,1]],"date-time":"1996-07-01T00:00:00Z","timestamp":836179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1996,7,1]],"date-time":"1996-07-01T00:00:00Z","timestamp":836179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drug Ther"],"published-print":{"date-parts":[[1996,7]]},"DOI":"10.1007\/bf02627954","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T10:55:42Z","timestamp":1691664942000},"page":"309-312","source":"Crossref","is-referenced-by-count":4,"title":["Renin Inhibitors: Cardiovascular drugs of the future?"],"prefix":"10.1007","volume":"10","author":[{"given":"Jeanette M.","family":"Wood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Close","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02627954_CR1","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ki.1992.383","volume":"42","author":"I Gavras","year":"1992","unstructured":"GavrasI. Bradykinin-medicated effects of ACE inhibition.Kidney Int 1992;42:1020\u20131029.","journal-title":"Kidney Int"},{"issue":"Suppl 3","key":"BF02627954_CR2","first-page":"136","volume":"18","author":"PBMWM Timmermans","year":"1991","unstructured":"TimmermansPBMWM, CariniDJ, ChiuAT, HerblinWF. Angiotensin II receptor antagonists: From discovery to antihypertensive drugs.Hypertension 1991;18(Suppl 3):136\u2013142.","journal-title":"Hypertension"},{"key":"BF02627954_CR3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1476-5381.1993.tb13877.x","volume":"110","author":"L Criscione","year":"1993","unstructured":"CriscioneL, deGasparoM, B\u00fchlmayerP, WhitebreadS, Ramjou\u00e9HPJ, WoodJM. Pharmacological profile of valsartan: A potent, orally active, nonpeptide antagonist of the angiotensin II AT-receptor subtype.Br J Pharmacol 1993; 110:761\u2013771.","journal-title":"Br J Pharmacol"},{"key":"BF02627954_CR4","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/BF00878547","volume":"9","author":"HD Kleinert","year":"1995","unstructured":"KleinertHD. Renin inhibition.Cardiovasc Drugs Ther 1995;9:645\u2013655.","journal-title":"Cardiovasc Drugs Ther"},{"key":"BF02627954_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0163-7258(94)90015-9","volume":"61","author":"JM Wood","year":"1994","unstructured":"WoodJM, CuminF, MaibaumJ. Pharmacology of renin inhibitors and their application to the treatment of hypertension.Pharm Ther 1994;61:325\u2013344.","journal-title":"Pharm Ther"},{"key":"BF02627954_CR6","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/00001573-199409000-00004","volume":"9","author":"CM Ferrario","year":"1994","unstructured":"FerrarioCM, ChappellMC. A hew myocardial conversion of angiotensin 1.Curr Opin Cardiol 1994;9:520\u2013526.","journal-title":"Curr Opin Cardiol"},{"issue":"Suppl 1","key":"BF02627954_CR7","first-page":"1","volume":"7","author":"J Nussberger","year":"1985","unstructured":"NussbergerJ, BrunnerDB, WaeberB, BrunnerHR. True versus immunoreactive angiotensin II in human plasma.Hypertension 1985;7(Suppl 1):1\u20137.","journal-title":"Hypertension"},{"key":"BF02627954_CR8","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/01.CIR.92.4.825","volume":"92","author":"M Azizi","year":"1995","unstructured":"AziziM, ChatellierG, GuyeneTT, Murieta-GeoffroyD, M\u00e9nardJ. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.Circulation 1995;92:825\u2013834.","journal-title":"Circulation"},{"key":"BF02627954_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/00005344-199207000-00010","volume":"20","author":"AA Fossa","year":"1992","unstructured":"FossaAA, WeinbergLJ, BarberRL, et al. Synergistic effect on reduction in blood pressure with coadministration of the renin inhibitor, CP-80,794, and the angiotensin converting enzyme inhibitor, captopril.J Cardiovasc Pharmacol 1992;20:75\u201382.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF02627954_CR10","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/ddr.430330405","volume":"33","author":"AA Fossa","year":"1994","unstructured":"FossaAA, DePasqualeMJ, RingerLJ, WinslowRL. Synergistic effect on reduction in blood pressure with coadministration of a renin inhibitor or an angiotensin-converting enzyme inhibitor with an angiotensin II receptor antagonist.Drug Dev Res 1994;33:422\u2013428.","journal-title":"Drug Dev Res"},{"issue":"Suppl 6","key":"BF02627954_CR11","first-page":"S468","volume":"9","author":"E Nelson","year":"1991","unstructured":"NelsonE, MerrillD, SweetC, et al. Efficacy and safety of oral MK-954 (Du753), an angiotensin receptor antagonist, in essential hypertension.J Hypertens 1991;9(Suppl 6): S468-S469.","journal-title":"J Hypertens"},{"key":"BF02627954_CR12","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1042\/bj2530907","volume":"253","author":"NJ Samani","year":"1988","unstructured":"SamaniNJ, SwalesJD, BrammarWJ. Expression of the renin gene in extrarenal tissues of the rat.Biochem J 1988; 253:907\u2013910.","journal-title":"Biochem J"},{"key":"BF02627954_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/00004872-199301000-00011","volume":"11","author":"J-P Clozel","year":"1993","unstructured":"ClozelJ-P, FischliW, M\u00e9nardJ. Effects of the blockade of the renin angiotensin system in cyclosporin-induced hypertension.J Hypertens 1993;11:75\u201381.","journal-title":"J Hypertens"},{"key":"BF02627954_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.CIR.85.1.1","volume":"85","author":"W Kiowski","year":"1992","unstructured":"KiowskiW, LinderL, KleinbloesemC, et al. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition.Circulation 1992;85:1\u20138.","journal-title":"Circulation"},{"key":"BF02627954_CR15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/00004872-199404000-00012","volume":"12","author":"M Aziz\u00ed","year":"1994","unstructured":"Aziz\u00edM, GuyeneTT, ChatellierG, M\u00e9nardJ. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.J Hypertens 1994;12:419\u2013427.","journal-title":"J Hypertens"},{"key":"BF02627954_CR16","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1097\/00004872-199308000-00010","volume":"11","author":"AH van den Meiracker","year":"1993","unstructured":"van denMeirackerAH, AdmiraalPJJ, DerkxFHM, et al. Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension.J Hypertens 1993;11:831\u2013838.","journal-title":"J Hypertens"},{"key":"BF02627954_CR17","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/01.CIR.91.2.330","volume":"91","author":"J M\u00e9nard","year":"1995","unstructured":"M\u00e9nardJ, BogerRS, MoyseDM, GuyeneTT, GlassmanHN, KleinertHD. Dose-dependent effects of the renin inhibitor zankiren HCl after a single oral dose in midly sodium-depleted normotensive subjects.Circulation 1995;91: 330\u2013338.","journal-title":"Circulation"},{"key":"BF02627954_CR18","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/01.CIR.81.6.1768","volume":"81","author":"MA Weber","year":"1990","unstructured":"WeberMA, NeutelJM, EssingerI, GlassmanHN, BogerRS, LutherR. Assessment of renin dependency of hypertension with a dipeptide renin inhibitor.Circulation 1990; 81:1768\u20131774.","journal-title":"Circulation"},{"key":"BF02627954_CR19","first-page":"539","volume":"15","author":"T Ogihara","year":"1993","unstructured":"OgiharaT, NaganoM, HigakiJ, HigashimoriK, MasuoK, MikamiH. Antihypertensive efficacy of FK906, a novel human renin inhibitor.Clin Ther 1993;15:539\u2013548.","journal-title":"Clin Ther"},{"key":"BF02627954_CR20","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1161\/01.HYP.15.6.835","volume":"15","author":"RS Boger","year":"1990","unstructured":"BogerRS, GlassmannHN, CavanaughJH, et al. Prolonged duration of blood pressure response to enalkiren, the novel dipeptide renin inhibitor, in essential hypertension.Hypertension 1990;15:835\u2013840.","journal-title":"Hypertension"},{"key":"BF02627954_CR21","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1161\/01.CIR.90.6.2748","volume":"90","author":"W Kiowski","year":"1994","unstructured":"KiowskiW, BeermannJ, RickenbacherP, et al. Angiotensinergic versus nonangiotensinergic hemodynamic effects of converting enzyme inhibition in patients with chronic heart failure. Assessment by acute renin and converting enzyme inhibition.Circulation. 1994;90:2748\u20132756.","journal-title":"Circulation"},{"key":"BF02627954_CR22","first-page":"253","volume":"38","author":"GW Neuberg","year":"1990","unstructured":"NeubergGW, PennJ, KukinML, et al. Hemodynamic effects of enalkiren, a direct inhibitor of plasma renin, in patients with chronic heart failure (abst).Clin Res 1990;38: 253.","journal-title":"Clin Res"},{"key":"BF02627954_CR23","first-page":"557","volume":"3","author":"TF Andoh","year":"1992","unstructured":"AndohTF, NagotomiI, HoriraiH, et al. Comparative effects of FK 906, an orally active renin inhibitor and captopril on blood pressure and renal hemodynamics in cynomolgus monkeys.J Am Soc Nephrol 1992;3:557.","journal-title":"J Am Soc Nephrol"},{"key":"BF02627954_CR24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/00005344-199308000-00010","volume":"22","author":"A Elamrani","year":"1993","unstructured":"ElamraniA, M\u00e9nardJ, GonzalesMF, MichelJB. Effects of blocking the angiotensin-II receptor, converting enzyme, and renin activity on the renal hemodynamics of normotensive guinea pigs.J Cardiovasc Pharmacol 1993;22:231\u2013239.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF02627954_CR25","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/01.HYP.26.4.602","volume":"26","author":"NK Hollenberg","year":"1995","unstructured":"HollenbergNK, FisherNDL. Renal circulation and blockade of the renin-angiotensin system. Is angiotensin-converting inhibition the last word?Hypertension 1995; 26:602\u2013609.","journal-title":"Hypertension"},{"key":"BF02627954_CR26","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1001\/archinte.151.7.1280","volume":"151","author":"National High Blood Pressure Education Program","year":"1991","unstructured":"National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group Report on Hypertension and Chronic Renal Failure.Arch Intern Med 1991;151:1280\u20131287.","journal-title":"Arch Intern Med"},{"key":"BF02627954_CR27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/bmj.304.6823.339","volume":"304","author":"ST Bjorck","year":"1992","unstructured":"BjorckST, MulecH, JohnsenSA, et al. Renal protective effect of enalapril in diabetic nephropathy.Br Med J 1992; 304:339\u2013343.","journal-title":"Br Med J"},{"key":"BF02627954_CR28","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","volume":"329","author":"EJ Lewis","year":"1993","unstructured":"LewisEJ, HunsickerLG, RohdeRP. The effects of angiotensin-converting-enzyme inhibition on diabetic nephropathy.N Engl J Med 1993;329:1456\u20131462.","journal-title":"N Engl J Med"},{"key":"BF02627954_CR29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/ajh\/5.7.423","volume":"5","author":"AL Kamper","year":"1992","unstructured":"KamperAL, StrandgaardS, LeyssacPP. Effect of enalapril on the progression of chronic renal failure. A randomized controlled trial.Am J Hypertens 1992;5:423\u2013430.","journal-title":"Am J Hypertens"},{"key":"BF02627954_CR30","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/bmj.309.6958.833","volume":"309","author":"T Hannedouche","year":"1994","unstructured":"HannedoucheT, LandaisP, GodfarbB, et al. Randomized controlled trial of enalapril and beta-blockers in non-diabetic chronic renal failure.Br Med J 1994;309:833\u2013837.","journal-title":"Br Med J"},{"key":"BF02627954_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0895-7061(95)00189-1","volume":"8","author":"E Ritz","year":"1995","unstructured":"RitzE. Are antihypertensive drugs similar in protecting the kidney?Am J Hypertens 1995;8(Suppl):53\u201358.","journal-title":"Am J Hypertens"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02627954.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02627954\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02627954.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T10:56:10Z","timestamp":1691664970000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02627954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,7]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1996,7]]}},"alternative-id":["BF02627954"],"URL":"https:\/\/doi.org\/10.1007\/bf02627954","relation":{},"ISSN":["0920-3206"],"issn-type":[{"value":"0920-3206","type":"print"}],"subject":[],"published":{"date-parts":[[1996,7]]}}}